Lv41
600 积分 2024-01-24 加入
Long Washout Periods Between Biologics for Inflammatory Bowel Disease Clinical Trials Are Unnecessary: A Canadian Retrospective Cohort Study
1个月前
已完结
Tumor necrosis factor (TNF) inhibitors for the treatment of psoriatic arthritis
1个月前
已完结
POS0152 LONG-TERM REAL-WORLD EFFECTIVENESS OF UPADACITINIB COMPARED TO TNFI IN RHEUMATOID ARTHRITIS
1个月前
已关闭
Comparative Safety of Janus Kinase inhibitors vs. Tumor Necrosis Factor Antagonists in Patients with Inflammatory Bowel Diseases
2个月前
已完结
Comparative Safety of Janus Kinase inhibitors vs. Tumor Necrosis Factor Antagonists in Patients with Inflammatory Bowel Diseases
2个月前
已完结
Vedolizumab Is Associated With a Lower Risk of Serious Infections Than Anti-Tumor Necrosis Factor Agents in Older Adults
3个月前
已关闭
Effectiveness and Safety of Tofacitinib in Biologic-Naïve Elderly Patients with Ulcerative Colitis
3个月前
已完结
Upadacitinib Dose Reduction Regimen in Elderly Patients with Atopic Dermatitis, Guided by Treat-to-Target Consensus Recommendations
4个月前
已完结
P1070 Comaparison of Effectiveness and Perisitence Anti-TNF drugs on Perianal Fistulizing Crohn’s Disease: A Single Tertiary IBD Referral Center Experience
5个月前
已关闭
P0996 JAK Inhibitors Open a New Chapter in IBD Treatment: a Monocentric Retrospective Observational Research
5个月前
已完结
皖公网安备34019202002308
